Turner G, Coureau C, Rabin M R, Escoubet B, Hruby M, Walrant O, Silve C
INSERM U-426, Faculté de Médecine Xavier Bichat, Paris, France.
Endocrinology. 1995 Sep;136(9):3751-8. doi: 10.1210/endo.136.9.7649081.
The aim of the present work was to characterize at the molecular level the mechanism of PTH resistance in a rat model of secondary hyperparathyroidism resulting from vitamin D deprivation. PTH/PTH-related protein (PTHrp) receptor messenger RNA (mRNA) expression, assayed by ribonuclease protection analysis, was studied in the kidney, femoral epi/metaphysis, and diaphysis. In addition, in the kidney, PTH/PTHrp receptor mRNA expression was correlated to receptor function by measuring adenyl cyclase activity in crude renal membranes after stimulation by PTH (10(-10) - 10(-6) M), forskolin (0.1 and 0.2 mM), NaF (5 and 10 mM), and isoproterenol (1 and 10 microM). Four groups of rats were studied to investigate the effects of calcium, PTH, and/or vitamin D status. The first group received a control diet (D+D+). The second group received a diet deficient in vitamin D until death (D-D-). In the two other groups that also received a vitamin D-deficient diet, the hypocalcemia and the hyperparathyroidism were later corrected, by either vitamin D supplementation (D-D+) or lactose and high calcium diet (D-Ca+), 1 week before death. The results revealed a 2-fold decrease in the PTH-induced adenyl cyclase activity of the renal membranes in the D-D- rats compared to those in the three other groups. There was no significant difference in the four groups in adenyl cyclase activity stimulated by forskolin, NaF, and isoproterenol. The decrease in PTH-induced adenyl cyclase activity was associated with an approximately 2-fold increase in PTH/PTHrp receptor mRNA expression in the kidneys of the D-D- rats compared to controls. Normalization of PTH/PTHrp receptor mRNA expression was observed after vitamin D supplementation (D-D+ rats), but not after correction of the hypocalcemia and secondary hyperparathyroidism by oral lactose and calcium supplementation. In the epi/metaphysis, an approximately 2-fold increase in PTH/PTHrp receptor mRNA was also observed in the D-D- rats compared to the controls; this increase was partially corrected upon normalization of the calcemia and PTH levels with either vitamin D (D-D+ group) or lactose/calcium (D-Ca+ group). In the diaphysis, no change in the expression of PTH/PTHrp receptor mRNA was observed in any group.(ABSTRACT TRUNCATED AT 400 WORDS)
本研究的目的是在分子水平上表征维生素D缺乏所致继发性甲状旁腺功能亢进大鼠模型中甲状旁腺激素(PTH)抵抗的机制。通过核糖核酸酶保护分析测定PTH/甲状旁腺激素相关蛋白(PTHrp)受体信使核糖核酸(mRNA)的表达,研究对象为肾脏、股骨骨骺/干骺端和骨干。此外,在肾脏中,通过测定PTH(10⁻¹⁰ - 10⁻⁶ M)、福斯高林(0.1和0.2 mM)、氟化钠(5和10 mM)以及异丙肾上腺素(1和10 μM)刺激后粗制肾膜中的腺苷酸环化酶活性,将PTH/PTHrp受体mRNA表达与受体功能相关联。研究了四组大鼠,以探讨钙、PTH和/或维生素D状态的影响。第一组给予对照饮食(D+D+)。第二组给予维生素D缺乏饮食直至死亡(D-D-)。在另外两组同样给予维生素D缺乏饮食的大鼠中,在死亡前1周通过补充维生素D(D-D+)或乳糖和高钙饮食(D-Ca+)纠正了低钙血症和甲状旁腺功能亢进。结果显示,与其他三组相比,D-D-大鼠肾膜中PTH诱导的腺苷酸环化酶活性降低了2倍。福斯高林、氟化钠和异丙肾上腺素刺激的腺苷酸环化酶活性在四组中无显著差异。PTH诱导的腺苷酸环化酶活性降低与D-D-大鼠肾脏中PTH/PTHrp受体mRNA表达相比对照增加了约2倍有关。补充维生素D后(D-D+大鼠)观察到PTH/PTHrp受体mRNA表达恢复正常,但口服乳糖和钙补充纠正低钙血症和继发性甲状旁腺功能亢进后未恢复正常。在骨骺/干骺端,与对照相比,D-D-大鼠中PTH/PTHrp受体mRNA也增加了约2倍;通过维生素D(D-D+组)或乳糖/钙(D-Ca+组)使血钙和PTH水平正常化后,这种增加得到部分纠正。在骨干中,任何组均未观察到PTH/PTHrp受体mRNA表达的变化。(摘要截短至400字)